Biologic & Biosimilar RA Drugs Global Market Report 2024

Biologic & Biosimilar RA Drugs Global Market Report 2024

Including: 1) By Source: Microbial; Mammalian2) By Disease: Oncology; Immunological Disorders; Cardiovascular Disorders; Hematological Disorders3) By Manufacturing: Outsourced; In-House4) By Mode Of Purchase: Prescription Drugs; Over-The-Counter (OTC) Drugs5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Samsung BioLogics Co. Ltd.; Amgen Inc.; Novo Nordisk A/S; AbbVie Inc.; Johnson & Johnson Services Inc.


Biologic & Biosimilar RA Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologic & biosimilar ra drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for biologic & biosimilar ra drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologic & biosimilar ra drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Source: Microbial; Mammalian; Other Sources

2) By Disease: Oncology; Immunological Disorders; Cardiovascular Disorders; Hematological Disorders; Other Diseases

3) By Manufacturing: Outsourced; In-House

4) By Mode Of Purchase: Prescription Drugs; Over-The-Counter (OTC) Drugs

5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Samsung BioLogics Co. Ltd.; Amgen Inc.; Novo Nordisk A/S; AbbVie Inc.; Johnson & Johnson Services Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Biologic & Biosimilar RA Drugs Market Characteristics
3. Biologic & Biosimilar RA Drugs Market Trends And Strategies
4. Biologic & Biosimilar RA Drugs Market - Macro Economic Scenario
4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market
5. Global Biologic & Biosimilar RA Drugs Market Size and Growth
5.1. Global Biologic & Biosimilar RA Drugs Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Biologic & Biosimilar RA Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Biologic & Biosimilar RA Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Biologic & Biosimilar RA Drugs Market Segmentation
6.1. Global Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Microbial
Mammalian
Other Sources
6.2. Global Biologic & Biosimilar RA Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oncology
Immunological Disorders
Cardiovascular Disorders
Hematological Disorders
Other Diseases
6.3. Global Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Outsourced
In-House
6.4. Global Biologic & Biosimilar RA Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Prescription Drugs
Over-The-Counter (OTC) Drugs
6.5. Global Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
7. Biologic & Biosimilar RA Drugs Market Regional And Country Analysis
7.1. Global Biologic & Biosimilar RA Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Biologic & Biosimilar RA Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Biologic & Biosimilar RA Drugs Market
8.1. Asia-Pacific Biologic & Biosimilar RA Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Biologic & Biosimilar RA Drugs Market
9.1. China Biologic & Biosimilar RA Drugs Market Overview
9.2. China Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Biologic & Biosimilar RA Drugs Market
10.1. India Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Biologic & Biosimilar RA Drugs Market
11.1. Japan Biologic & Biosimilar RA Drugs Market Overview
11.2. Japan Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Biologic & Biosimilar RA Drugs Market
12.1. Australia Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Biologic & Biosimilar RA Drugs Market
13.1. Indonesia Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Biologic & Biosimilar RA Drugs Market
14.1. South Korea Biologic & Biosimilar RA Drugs Market Overview
14.2. South Korea Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Biologic & Biosimilar RA Drugs Market
15.1. Western Europe Biologic & Biosimilar RA Drugs Market Overview
15.2. Western Europe Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Biologic & Biosimilar RA Drugs Market
16.1. UK Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Biologic & Biosimilar RA Drugs Market
17.1. Germany Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Biologic & Biosimilar RA Drugs Market
18.1. France Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Biologic & Biosimilar RA Drugs Market
19.1. Italy Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Biologic & Biosimilar RA Drugs Market
20.1. Spain Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Biologic & Biosimilar RA Drugs Market
21.1. Eastern Europe Biologic & Biosimilar RA Drugs Market Overview
21.2. Eastern Europe Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Biologic & Biosimilar RA Drugs Market
22.1. Russia Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Biologic & Biosimilar RA Drugs Market
23.1. North America Biologic & Biosimilar RA Drugs Market Overview
23.2. North America Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Biologic & Biosimilar RA Drugs Market
24.1. USA Biologic & Biosimilar RA Drugs Market Overview
24.2. USA Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Biologic & Biosimilar RA Drugs Market
25.1. Canada Biologic & Biosimilar RA Drugs Market Overview
25.2. Canada Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Biologic & Biosimilar RA Drugs Market
26.1. South America Biologic & Biosimilar RA Drugs Market Overview
26.2. South America Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Biologic & Biosimilar RA Drugs Market
27.1. Brazil Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Biologic & Biosimilar RA Drugs Market
28.1. Middle East Biologic & Biosimilar RA Drugs Market Overview
28.2. Middle East Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Biologic & Biosimilar RA Drugs Market
29.1. Africa Biologic & Biosimilar RA Drugs Market Overview
29.2. Africa Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Biologic & Biosimilar RA Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Biologic & Biosimilar RA Drugs Market Competitive Landscape And Company Profiles
30.1. Biologic & Biosimilar RA Drugs Market Competitive Landscape
30.2. Biologic & Biosimilar RA Drugs Market Company Profiles
30.2.1. Samsung BioLogics Co. Ltd.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Amgen Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Novo Nordisk A/S
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. AbbVie Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Johnson & Johnson Services Inc
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Global Biologic & Biosimilar RA Drugs Market Competitive Benchmarking
32. Global Biologic & Biosimilar RA Drugs Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Biologic & Biosimilar RA Drugs Market
34. Biologic & Biosimilar RA Drugs Market Future Outlook and Potential Analysis
34.1 Biologic & Biosimilar RA Drugs Market In 2028 - Countries Offering Most New Opportunities
34.2 Biologic & Biosimilar RA Drugs Market In 2028 - Segments Offering Most New Opportunities
34.3 Biologic & Biosimilar RA Drugs Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies
35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings